June 2017

Phase 1 results will inform potential Phase 2 studies in patients with fibromyalgia and neuropathic pain, planned to start in 2H17 Study includes single rising dose and multiple rising dose evaluations DEVON, Pa., June 26, 2017 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (NASDAQ:ZYNE), a clinical-stage specialty pharmaceutical company dedicated to developing and commercializing innovative transdermal […]

CBD could help lower your blood pressure, a new study has found. Oral administration of cannabidiol was associated with reduced blood pressure in healthy subjects, according to clinical trial data published online in the Journal of Clinical Investigation. University of Nottingham researchers observed the effects of a single oral dose of 600 mg of CBD […]

(CBS) – A landmark clinical trial has shown that a compound in marijuana can ease life-threatening seizures in children with a rare and devastating form of epilepsy. Cannabidiol — a non-intoxicating chemical — reduced seizure frequency by 39 percent in patients with Dravet Syndrome, researchers report. This is the first randomized, controlled trial to show […]

– Pharmaceutical formulation of cannabidiol significantly reduced convulsive seizure frequency in children on multiple anti-epileptic drugs with poor seizure control – – First well-controlled clinical study of cannabidiol in Dravet syndrome, a rare, severe type of epilepsy with no FDA-approved treatments – London, UK, May 25, 2017 – GW Pharmaceuticals plc (Nasdaq: GWPH, “GW,” “the Company” or […]

Make a list of the biotech and pharmaceutical companies developing marijuana-based, or cannabis, treatments, and GW Pharmaceuticals PLC (GWPH​) is most certainly going to occupy the top spot. The U.K.-based biopharmaceutical company, founded in 1998, is involved in the development of medications using its exclusive cannabinoid product platform. The company is currently assessing the potential […]

<!– /* Raw 300px */ (adsbygoogle = window.adsbygoogle || []).push({}); –> (function() { var sc = document.createElement(‘script’); sc.type = ‘text/javascript’; sc.async = true; sc.src = ‘//news.fark.com/data/js/84690.js’; sc.charset = ‘utf-8’; var s = document.getElementsByTagName(‘script’)[0]; s.parentNode.insertBefore(sc, s); }()); … read more at: http://www.rawstory.com/2017/06/could-taking-a-selfie-trigger-epilepsy/

University of Nottingham (Source: nottingham.ac.uk) Oxford, United Kingdom–(ENEWSPF)–June 22, 2017.  Oral CBD administration is associated with reduced blood pressure in healthy volunteers, according to clinical trial data published online in the Journal of Clinical Investigation. Investigators from the University of Nottingham assessed the effects of a single oral dose of 600 mg of CBD extract […]

Shortly after Tres Johnson was born, doctors gave him zero chance of survival. In the years following, different medics, at various stages, reaffirmed that crushing prognosis – death was imminent. However, the miracle boy has just celebrated his 13th birthday as he continues to defy the odds and leave top medical professionals positively baffled. Tres,, […]

By Sola Ogundipe A boy born with a rare “two face” condition has defied all odds to celebrate his 13th birthday. Tres Johnson from Bernie in Missouri, US, marked the milestone—despite doctors giving him “zero chance of survival” when he was born. He has craniofacial duplication, whereby parts or all of the face are duplicated […]